{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:52:35Z","timestamp":1790805155192,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Evidence-Based Dental Practice"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jebdp.2022.101778","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T12:58:00Z","timestamp":1663160280000},"page":"101778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["COMPARATIVE EFFICACY OF ANTIVIRAL AGENTS FOR PREVENTION AND MANAGEMENT OF HERPES LABIALIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS"],"prefix":"10.1016","volume":"23","author":[{"given":"Kim Hoe","family":"Koe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajesh K","family":"Veettil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari Kannan","family":"Maharajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Sakil","family":"Syeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athira Balakrishnan","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4279-7420","authenticated-orcid":false,"given":"Divya","family":"Gopinath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jebdp.2022.101778_bib0001","unstructured":"Herpes & Shingles: Symptoms & treatments - life extension [Internet]. [cited 2021 Sep 19]. Available from: https:\/\/www.lifeextension.com\/protocols\/infections\/herpes-and-shingles"},{"key":"10.1016\/j.jebdp.2022.101778_bib0002","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11908-006-0057-x","article-title":"The diagnosis and management of oral herpes simplex infection","volume":"8","author":"Birek","year":"2006","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jebdp.2022.101778_bib0003","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1038\/s41598-020-63530-6","article-title":"Clinical study on the effectiveness of three products in the treatment of Herpes simplex labialis","volume":"10","author":"Boes","year":"2020","journal-title":"Scientific Reports"},{"issue":"suppl_1","key":"10.1016\/j.jebdp.2022.101778_bib0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/47.suppl_1.17","article-title":"The many challenges of facial herpes simplex virus infection","volume":"47","author":"Esmann","year":"2001","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.jebdp.2022.101778_bib0005","unstructured":"Zeichner J. Acyclovir buccal adhesive tablet. Clinical insights - practical dermatology [Internet]. 2016 Jan [cited 2021 Mar 22]; Available from: https:\/\/practicaldermatology.com\/pdfs\/0116_insert.pdf"},{"key":"10.1016\/j.jebdp.2022.101778_bib0006","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fmicb.2020.00139","article-title":"Current antivirals and novel botanical molecules interfering with Herpes simplex virus infection","volume":"11","author":"\u00c1lvarez","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jebdp.2022.101778_bib0007","doi-asserted-by":"crossref","first-page":"8891","DOI":"10.3390\/ijerph17238891","article-title":"Antiviral agents for the prevention and treatment of Herpes simplex virus Type-1 infection in clinical oncology: a network meta-analysis","volume":"17","author":"Aribi Al-Zoobaee","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jebdp.2022.101778_bib0008","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jclinepi.2016.11.015","article-title":"Additional considerations are required when preparing a protocol for a systematic review with multiple interventions","volume":"83","author":"Chaimani","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.jebdp.2022.101778_bib0009","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA Extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jebdp.2022.101778_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Medical Research Methodology"},{"key":"10.1016\/j.jebdp.2022.101778_bib0011","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jebdp.2022.101778_bib0012","unstructured":"Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011].The Cochrane Collaboration. [Internet]. 2011. Available from: http:\/\/handbook.cochrane.org\/."},{"key":"10.1016\/j.jebdp.2022.101778_bib0013","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1136\/archdischild-2018-315224","article-title":"Network meta-analysis explained","volume":"104","author":"Dias","year":"2019","journal-title":"Archives of Disease in Childhood -Fetal and Neonatal Edition"},{"key":"10.1016\/j.jebdp.2022.101778_bib0014","doi-asserted-by":"crossref","unstructured":"Hoaglin DC, Hawkins N, Jansen JP, et al. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR task force on indirect treatment comparisons good research practices: part 2. value health. 2011 Jun;14:429\u201337.","DOI":"10.1016\/j.jval.2011.01.011"},{"key":"10.1016\/j.jebdp.2022.101778_bib0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2288-14-131","article-title":"Visualizing inconsistency in network meta-analysis by independent path decomposition","volume":"14","author":"Krahn","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1016\/j.jebdp.2022.101778_bib0016","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jebdp.2022.101778_bib0017","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1167","article-title":"Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis","volume":"7","author":"van Valkenhoef","year":"2016","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jebdp.2022.101778_bib0018","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jebdp.2022.101778_bib0019","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jebdp.2022.101778_bib0020","first-page":"791","article-title":"Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial","volume":"13","author":"Bieber","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.jebdp.2022.101778_bib0021","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02919055","article-title":"Prevention of recurrences in frequently relapsing herpes labialis with thymopentin. A randomized double-blind placebo-controlled multicenter study","volume":"4","author":"Bolla","year":"1985","journal-title":"Surv Immunol Res"},{"key":"10.1016\/j.jebdp.2022.101778_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026201","article-title":"Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial","volume":"9","author":"Semprini","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jebdp.2022.101778_bib0023","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/jama.1988.03410110105036","article-title":"Acyclovir prevents reactivation of Herpes simplex labialis in Skiers","volume":"260","author":"Spruance","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.jebdp.2022.101778_bib0024","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1079-2104(97)90366-8","article-title":"Herpes labialis in skiers: randomized clinical trial of acyclovir cream versus placebo","volume":"84","author":"Raborn","year":"1997","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics"},{"key":"10.1016\/j.jebdp.2022.101778_bib0025","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/AAC.47.3.1072-1080.2003","article-title":"High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies","volume":"47","author":"Spruance","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jebdp.2022.101778_bib0026","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1128\/AAC.46.7.2238-2243.2002","article-title":"Acyclovir cream for treatment of Herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials","volume":"46","author":"Spruance","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.jebdp.2022.101778_bib0027","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.oooo.2015.08.018","article-title":"Topical lipophilic epigallocatechin-3-gallate on herpes labialis: a phase II clinical trial of AverTeaX formula","volume":"120","author":"Zhao","year":"2015","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"},{"key":"10.1016\/j.jebdp.2022.101778_bib0028","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/archderm.1977.01640110070010","article-title":"Topical treatment of Herpes labialis with chloroform","volume":"113","author":"Taylor","year":"1977","journal-title":"Archives of Dermatology"},{"key":"10.1016\/j.jebdp.2022.101778_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8562309","article-title":"Efficacy of pleuran (\u03b2-Glucan from pleurotus ostreatus) in the management of Herpes simplex virus type 1 infection","volume":"2020","author":"Urbancikova","year":"2020","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"10.1016\/j.jebdp.2022.101778_bib0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1468-3083.2008.03047.x","article-title":"Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial","volume":"23","author":"Hull","year":"2009","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1016\/j.jebdp.2022.101778_bib0031","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000057255","article-title":"Combined herbal preparation for topical treatment of Herpes labialis","volume":"8","author":"Saller","year":"2001","journal-title":"Complement Med Res"},{"key":"10.1016\/j.jebdp.2022.101778_bib0032","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10354-018-0667-6","article-title":"Lip creams with propolis special extract GH 2002 0.5% versus aciclovir 5.0% for herpes labialis (vesicular stage): randomized, controlled double-blind study","volume":"169","author":"Jautov\u00e1","year":"2019","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.jebdp.2022.101778_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.curtheres.2017.10.004","article-title":"Comparative study with a lip balm containing 0.5% propolis special extract GH 2002 versus 5% aciclovir cream in patients with Herpes labialis in the papular\/erythematous stage: a single-blind, randomized, two-arm Study","volume":"88","author":"Arenberger","year":"2017","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.jebdp.2022.101778_bib0034","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jaad.2010.08.012","article-title":"Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial","volume":"64","author":"Hull","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.jebdp.2022.101778_bib0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0944-7113(11)80019-X","article-title":"Local therapy of herpes simplex with dried extract from Melissa officinalis","volume":"1","author":"W\u00f6lbling","year":"1994","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jebdp.2022.101778_bib0036","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/095466302317584412","article-title":"Topical application of penciclovir cream for the treatment of herpes simplex facialis\/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial","volume":"13","author":"Lin","year":"2002","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1016\/j.jebdp.2022.101778_bib0037","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jac\/12.suppl_B.89","article-title":"Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections","volume":"12","author":"Van Vloten","year":"1983","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.jebdp.2022.101778_bib0038","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s13555-021-00531-x","article-title":"A randomized exploratory study to investigate the inflammatory response during an ultraviolet-radiation-induced cold sore episode","volume":"11","author":"Veltri","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jebdp.2022.101778_bib0039","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0190-9622(99)70260-4","article-title":"A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis","volume":"41","author":"Kaminester","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.jebdp.2022.101778_bib0040","doi-asserted-by":"crossref","unstructured":"Rowe NH, Brooks SL, Young SK, et al. A clinical trial of topically applied 3 percent vidarabine against recurrent herpes labialis. Oral Surg Oral Med Oral Pathol. 1979 Feb;47:142\u20137.","DOI":"10.1016\/0030-4220(79)90169-5"},{"key":"10.1016\/j.jebdp.2022.101778_bib0041","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/infdis\/137.5.597","article-title":"A double-blind, controlled trial of levamisole in the treatment of recurrent Herpes labialis","volume":"137","author":"Russell","year":"1978","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.jebdp.2022.101778_bib0042","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/AAC.15.5.662","article-title":"Treatment of recurrent Herpes simplex labialis with levamisole","volume":"15","author":"Spruance","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jebdp.2022.101778_bib0043","article-title":"The efficacy of olive leaf extract on healing herpes simplex virus labialis: a randomized double-blind study","author":"Toulabi","year":"2021","journal-title":"Explore (NY)"},{"key":"10.1016\/j.jebdp.2022.101778_bib0044","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/1346-8138.12845","article-title":"Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients","volume":"42","author":"You","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jebdp.2022.101778_bib0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0714.2011.01037.x","article-title":"A study of the clinical activity of a gel combining monocaprin and doxycycline: a novel treatment for herpes labialis","volume":"41","author":"Skulason","year":"2012","journal-title":"Journal of Oral Pathology & Medicine"},{"key":"10.1016\/j.jebdp.2022.101778_bib0046","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/clpt.1985.134","article-title":"Treatment of recurrent herpes simplex labialis with topical butylated hydroxytoluene","volume":"38","author":"Freeman","year":"1985","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.jebdp.2022.101778_bib0047","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/09546630701593457","article-title":"Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trial","volume":"19","author":"Zschocke","year":"2008","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1016\/j.jebdp.2022.101778_bib0048","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaad.2006.02.031","article-title":"Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis","volume":"55","author":"Spruance","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jebdp.2022.101778_bib0049","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0149-2918(00)87979-5","article-title":"Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial","volume":"22","author":"Boon","year":"2000","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.jebdp.2022.101778_bib0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1086\/314605","article-title":"Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced Herpes simplex labialis: a double-blind, dose-ranging, placebo-controlled, multicenter trial","volume":"179","author":"Spruance","year":"1999","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.jebdp.2022.101778_bib0051","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0002-9343(82)90115-2","article-title":"Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis: antiviral effect without clinical benefit","volume":"73","author":"Spruance","year":"1982","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.jebdp.2022.101778_bib0052","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/AAC.25.5.553","article-title":"patient-initiated treatment of herpes labialis with topical 10% acyclovir","volume":"25","author":"Spruance","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jebdp.2022.101778_bib0053","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s12325-009-0049-y","article-title":"Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial","volume":"26","author":"Busch","year":"2009","journal-title":"Advances in therapy"},{"key":"10.1016\/j.jebdp.2022.101778_bib0054","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1079-2104(99)70164-2","article-title":"A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis","volume":"87","author":"Horwitz","year":"1999","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics"},{"key":"10.1016\/j.jebdp.2022.101778_bib0055","unstructured":"Ahadian H, Karbasi A, Ghanea S. Comparison of the effectiveness of mellisan gel and acyclovir 5% cream in the improvement of recurrent Herpes labialis. 2015;7."},{"key":"10.1016\/j.jebdp.2022.101778_bib0056","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/AAC.46.6.1870-1874.2002","article-title":"Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced Herpes labialis","volume":"46","author":"Evans","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jebdp.2022.101778_bib0057","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1086\/514042","article-title":"Topical undecylenic acid for Herpes simplex labialis: a multicenter, placebo-controlled trial","volume":"176","author":"Shafran","year":"1997","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.jebdp.2022.101778_bib0058","first-page":"239","article-title":"Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies","volume":"71","author":"Baker","year":"2003","journal-title":"Cutis"},{"key":"10.1016\/j.jebdp.2022.101778_bib0059","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0944-7113(99)80013-0","article-title":"Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis","volume":"6","author":"Koytchev","year":"1999","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jebdp.2022.101778_bib0060","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.14219\/jada.archive.2004.0407","article-title":"The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures","volume":"135","author":"Miller","year":"2004","journal-title":"The Journal of the American Dental Association"},{"key":"10.1016\/j.jebdp.2022.101778_bib0061","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/infdis\/161.2.185","article-title":"Treatment of recurrent Herpes simplex labialis with oral acyclovir","volume":"161","author":"Spruance","year":"1990","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.jebdp.2022.101778_bib0062","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/infdis\/154.6.930","article-title":"Iontophoresis of vidarabine monophosphate for Herpes orolabialis","volume":"154","author":"Sr","year":"1986","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.jebdp.2022.101778_bib0063","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14219\/jada.archive.1987.0211","article-title":"Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study","volume":"115","author":"Raborn","year":"1987","journal-title":"The Journal of the American Dental Association"},{"key":"10.1016\/j.jebdp.2022.101778_bib0064","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/infdis\/163.4.728","article-title":"The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir","volume":"163","author":"Spruance","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jebdp.2022.101778_bib0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.aimed.2014.09.001","article-title":"Randomised controlled trial of topical kanuka honey for the treatment of cold sores","volume":"1","author":"Fingleton","year":"2014","journal-title":"Advances in Integrative Medicine"},{"key":"10.1016\/j.jebdp.2022.101778_bib0066","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1034\/j.1601-0825.2001.70404.x","article-title":"LongoVital\u00ae and herpes labialis: a randomised, double blind, placebo-controlled study","volume":"7","author":"Pedersen","year":"2001","journal-title":"Oral Diseases"},{"key":"10.1016\/j.jebdp.2022.101778_bib0067","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/AAC.41.9.1961","article-title":"Effect of foscarnet cream on experimental UV radiation-induced herpes labialis","volume":"41","author":"Bernstein","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jebdp.2022.101778_bib0068","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1056\/NEJM197905243002103","article-title":"Ineffectiveness of topical adenine arabinoside 5\u2032-monophosphate in the treatment of ecurrent Herpes simplex labialis","volume":"300","author":"Spruance","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jebdp.2022.101778_bib0069","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.1980.03300360031020","article-title":"Topical ether and Herpes simplex labialis","volume":"243","author":"Guinan","year":"1980","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jebdp.2022.101778_bib0070","first-page":"85","article-title":"An open-label study conducted to evaluate the efficacy of betadine\u00ae cold sore paint","volume":"195","author":"Simmons","year":"1997","journal-title":"DRM"},{"key":"10.1016\/j.jebdp.2022.101778_bib0071","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0030-4220(89)90007-8","article-title":"Herpes labialis treatment with acyclovir 5% modified aqueous cream: a double-blind randomized trial","volume":"67","author":"Raborn","year":"1989","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.jebdp.2022.101778_bib0072","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.arthro.2021.04.070","article-title":"Understanding network meta-analysis (NMA) conclusions requires scrutiny of methods and results: introduction to NMA and the geometry of evidence","volume":"37","author":"Cote","year":"2021","journal-title":"Arthroscopy: The Journal of Arthroscopic & Related Surgery"},{"key":"10.1016\/j.jebdp.2022.101778_bib0073","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/095632020301400405","article-title":"ME-609: a treatment for recurrent Herpes simplex virus infections","volume":"14","author":"Harmenberg","year":"2003","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.jebdp.2022.101778_bib0074","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0166-3542(98)00003-5","article-title":"Herpes simplex virus zosteriform lesions with adoptive transfer of immune cells: a murine model which mimics human recurrent disease","volume":"38","author":"Awan","year":"1998","journal-title":"Antiviral Research"},{"key":"10.1016\/j.jebdp.2022.101778_bib0075","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1086\/315528","article-title":"Combination treatment with famciclovir and a topical corticosteroid gel versus famciclovir alone for experimental ultraviolet Radiation-induced Herpes simplex labialis: a pilot study","volume":"181","author":"Spruance","year":"2000","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.jebdp.2022.101778_bib0076","first-page":"52","article-title":"Are steroids a beneficial adjunctive therapy in the immunosuppressed patient with Herpes simplex virus encephalitis?","volume":"5","author":"Lizarraga","year":"2013","journal-title":"CRN"},{"key":"10.1016\/j.jebdp.2022.101778_bib0077","first-page":"225","article-title":"Beneficial effect of steroid pulse therapy on acute viral encephalitis","volume":"50","author":"Nakano","year":"2003","journal-title":"ENE"},{"key":"10.1016\/j.jebdp.2022.101778_bib0078","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0161-6420(94)31087-6","article-title":"Herpetic eye disease study: a controlled trial of topical corticosteroids for Herpes simplex stromal keratitis","volume":"101","author":"Wilhelmus","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jebdp.2022.101778_bib0079","first-page":"135","article-title":"Choosing topical corticosteroids","volume":"79","author":"Ference","year":"2009","journal-title":"AFP"},{"issue":"4","key":"10.1016\/j.jebdp.2022.101778_bib0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4103\/0019-5154.97655","article-title":"Rational and ethical use of topical corticosteroids based on safety and efficacy","volume":"57","author":"Rathi","year":"2012","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jebdp.2022.101778_bib0081","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jop.12534","article-title":"Efficacy and safety of nucleoside antiviral drugs for treatment of recurrent herpes labialis: a systematic review and meta-analysis","volume":"46","author":"Chen","year":"2017","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jebdp.2022.101778_bib0082","doi-asserted-by":"crossref","first-page":"118","DOI":"10.33590\/emjdermatol\/10311121","article-title":"A systematic review on the efficacy of topical Acyclovir, Penciclovir, and Docosanol for the treatment of Herpes simplex labialis","author":"Hammer","year":"2018","journal-title":"EMJ Dermatol"},{"key":"10.1016\/j.jebdp.2022.101778_bib0083","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1590\/0001-3765201520140701","article-title":"Efficacy of topical 5% Acyclovir-1% Hydrocortisone cream (ME-609) for treatment of Herpes labialis: a systematic review","volume":"87","author":"Rosa","year":"2015","journal-title":"An Acad Bras Ci\u00eanc"},{"key":"10.1016\/j.jebdp.2022.101778_bib0084","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/jof7080637","article-title":"Comparative efficacy of antifungal agents used in the treatment of oropharyngeal candidiasis among HIV-infected adults: a systematic review and network meta-analysis","volume":"7","author":"Rajadurai","year":"2021","journal-title":"J. Fungi"},{"key":"10.1016\/j.jebdp.2022.101778_bib0085","first-page":"559","article-title":"A network meta-analysis to compare the efficacy of steroid and antiviral medications for facial paralysis from bell\u00b4s palsy","volume":"21","author":"Fu","year":"2018","journal-title":"Pain Physician"},{"key":"10.1016\/j.jebdp.2022.101778_bib0086","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s10103-018-2542-5","article-title":"Efficacy of low-level laser therapy in management of recurrent herpes labialis: a systematic review","volume":"33","author":"Al-Maweri","year":"2018","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.jebdp.2022.101778_bib0087","doi-asserted-by":"crossref","unstructured":"Lotufo MA, Tempestini Horliana ACR, Santana T, et al. \u201cEfficacy of photodynamic therapy on the treatment of herpes labialis: a systematic review\u201d. Photodiagnosis and photodynamic therapy. 2020 Mar 1;29:101536.","DOI":"10.1016\/j.pdpdt.2019.08.018"},{"key":"10.1016\/j.jebdp.2022.101778_bib0088","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/odi.13588","article-title":"Antifungal agents in preventing oral candidiasis in clinical oncology: A network meta-analysis","volume":"27","author":"Shen Loo","year":"2021","journal-title":"Oral Dis"},{"key":"10.1016\/j.jebdp.2022.101778_bib0089","first-page":"133","article-title":"How to perform and interpret a network meta-analysis for indirect and mixed comparisons: key methodological strategies","author":"Santos","year":"2016","journal-title":"Rev Enf Ref"},{"key":"10.1016\/j.jebdp.2022.101778_bib0090","first-page":"333","article-title":"Network meta-analysis to synthesize evidence for secision making in cardiovascular research","volume":"106","author":"Roever","year":"2016","journal-title":"Arq Bras Cardiol"}],"container-title":["Journal of Evidence-Based Dental Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1532338222001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1532338222001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:55:10Z","timestamp":1761519310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1532338222001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1532338222001014"],"URL":"https:\/\/doi.org\/10.1016\/j.jebdp.2022.101778","relation":{},"ISSN":["1532-3382"],"issn-type":[{"value":"1532-3382","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COMPARATIVE EFFICACY OF ANTIVIRAL AGENTS FOR PREVENTION AND MANAGEMENT OF HERPES LABIALIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS","name":"articletitle","label":"Article Title"},{"value":"Journal of Evidence-Based Dental Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jebdp.2022.101778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101778"}}